Ponatinib
Generic name: Pronounced as (poe na' ti nib)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 04/15/2021
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
IMPORTANT WARNING
Ponatinib may cause serious or life-threatening blood clots in your legs or lungs, heart attacks, or strokes. Tell your doctor if you have or have ever had a blood clot in your lungs or legs; a stroke; high blood pressure; hyperlipidemia (high levels of cholesterol in your blood); a slow, fast, or irregular heartbeat; peripheral vascular disease (narrowing of blood vessels in feet, legs, or arms causing numbness, pain, or coldness in that part of the body); a heart attack; or heart disease. If you experience any of the following symptoms, call your doctor immediately: chest pain; shortness of breath; dizziness or fainting; sudden confusion or trouble speaking or understanding; sudden numbness or weakness of face, arm, or leg on one side of the body; sudden severe headache; leg, arm, back, neck, or jaw pain; feeling of warmth in the lower leg; or swelling of the feet, ankles, or lower legs.
Ponatinib may cause serious or life-threatening heart failure (condition in which the heart is unable to pump enough blood to the other parts of the body) and arrhythmias (abnormal heart rhythms). Tell your doctor if you have or have ever had heart problems, including heart failure, QT prolongation (an irregular heart rhythm that can lead to fainting, loss of consciousness, seizures, or sudden death); or a slow, fast, or irregular heartbeat. If you experience any of the following symptoms, call your doctor immediately: shortness of breath; chest pain; fast, irregular, or pounding heartbeat; dizziness; or fainting.
Ponatinib may cause serious or life-threatening damage to the liver. Tell your doctor if you have or have ever had liver disease or problems with your liver. If you experience any of the following symptoms, call your doctor immediately: itching, yellow eyes or skin, dark urine, or pain or discomfort in the right upper stomach area.
Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests before you start and during your treatment to check your body's response to ponatinib.
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with ponatinib and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.
Why is this medication prescribed?
Ponatinib is used to treat certain types of chronic myeloid leukemia (CML; a type of cancer of the white blood cells), including treatment in people who can no longer benefit from other medications for CML or who cannot take these medications because of side effects. Ponatinib is also used to treat certain types of acute lymphoblastic leukemia (ALL; a type of cancer of the white blood cells) in people who can no longer benefit from other medications for leukemia or who cannot take these medications because of side effects. Ponatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.
How should this medicine be used?
Ponatinib comes as a tablet to take by mouth. It is usually taken once a day with or without food. Take ponatinib at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take ponatinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Swallow the tablets whole; do not split, chew, or crush them.
Your doctor may need to delay your treatment, adjust your dose, or permanently stop your treatment of ponatinib depending on your response to treatment and any side effects that you experience. Talk to your doctor about how you are feeling during your treatment. Continue to take ponatinib even if you feel well. Do not stop taking ponatinib without talking to your doctor.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking ponatinib,
-
tell your doctor and pharmacist if you are allergic to ponatinib, any other medications, lactose, or any of the ingredients in ponatinib tablets. Ask your pharmacist or check the Medication Guide for a list of the ingredients.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: ketoconazole (Nizoral); medications to reduce stomach acid, such as lansoprazole (Prevacid); and rifampin (Rifadin, Rimactane, in Rifamate, in Rifater). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with ponatinib, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.
-
tell your doctor if you have or have ever had a bleeding problem; diabetes; pancreatitis (swelling of the pancreas, a gland behind the stomach that produces substances to help with digestion); or if you are lactose intolerant (inability to digest dairy products). Also, tell your doctor if you drink or have ever drunk large amounts of alcohol.
-
you should know that ponatinib may decrease fertility in women. However, you should not assume that you or your partner cannot become pregnant. Tell your doctor if you are pregnant or plan to become pregnant. If you are female, you will need to take a pregnancy test before you start treatment. You should use birth control to prevent pregnancy during your treatment with ponatinib and for 3 weeks after you stop taking the medication. Talk to your doctor about types of birth control that will work for you. If you become pregnant while taking ponatinib, call your doctor immediately. Ponatinib may harm the fetus.
-
tell your doctor if you are breastfeeding or plan to breastfeed. You should not breastfeed while taking ponatinib and for 6 days after your final dose.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking ponatinib. If you are scheduled to have surgery, your doctor will tell you to stop taking ponatinib for at least 7 days before the surgery or procedure. Your doctor will tell you when to start taking ponatinib again after your surgery.
-
you should know that your blood pressure may increase during your treatment with ponatinib. Your doctor will probably monitor your blood pressure during your treatment.
What special dietary instructions should I follow?
Do not eat large amounts of grapefruit or drink grapefruit juice while taking this medication.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Ponatinib may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
rash
-
dry skin
-
diarrhea
-
constipation
-
hair loss
-
white patches or sores on the lips or in the mouth and throat
-
loss of appetite
-
weight loss
-
cough
-
difficulty falling asleep or staying asleep
-
back, bone, joint, limb, or muscle pain
-
-
Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, stop taking ponatinib and call your doctor immediately or get emergency medical treatment:
-
unusual bruising or bleeding
-
bloody or black, tarry stools
-
blood in the urine
-
bloody vomit
-
unusual vaginal bleeding or heavier than usual menstrual bleeding
-
vomit that looks like coffee grounds
-
frequent nose bleeds
-
coughing up blood
-
dry, red, painful, or irritated eyes
-
sensitivity to light
-
blurred vision, floaters, double vision, or other vision changes
-
wounds that do not heal
-
fever, sore throat, chills, or other signs of infection
-
changes in taste; muscle weakness; drooping eyelids or part of face; tingling, burning, pain, or loss of feeling in hands or feet
-
headache, seizures, confusion, problems thinking, or changes or loss of vision
-
decreased urination
-
extreme tiredness or weakness
-
weight gain
-
swelling of your face, hands, feet, ankles, or lower legs
-
pain, swelling, or tenderness in the abdomen (stomach area)
-
nausea
-
vomiting
-
ongoing pain that begins in the stomach area but may spread to the back
-
-
Ponatinib may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include the following:
-
fever, sore throat, chills, and other signs of infection
-
rapid, irregular, or pounding heartbeat
-
tiredness
-
chest pain
What OTHER INFORMATION should I know?
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Repaglinide | Repaglinide The metabolism of Repaglinide can be decreased when combined with Ponatinib. |
Montelukast | Montelukast The metabolism of Ponatinib can be decreased when combined with Montelukast. |
Leflunomide | Leflunomide The risk or severity of adverse effects can be increased when Ponatinib is combined with Leflunomide. |
Delavirdine | Delavirdine The metabolism of Ponatinib can be decreased when combined with Delavirdine. |
Nevirapine | Nevirapine The metabolism of Ponatinib can be decreased when combined with Nevirapine. |
Atorvastatin | Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Ponatinib. |
Dolasetron | Dolasetron The metabolism of Ponatinib can be decreased when combined with Dolasetron. |
Anagrelide | Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Ponatinib. |
Candesartan | Candesartan The metabolism of Ponatinib can be decreased when combined with Candesartan. |
Cilostazol | Cilostazol The metabolism of Ponatinib can be decreased when combined with Cilostazol. |
Clopidogrel | Clopidogrel The metabolism of Ponatinib can be decreased when combined with Clopidogrel. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole The metabolism of Ponatinib can be decreased when combined with Erythromycin. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Ponatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level. |
Fenofibrate | Fenofibrate The metabolism of Ponatinib can be decreased when combined with Fenofibrate. |
Methylergonovine | Methylergonovine The metabolism of Ponatinib can be decreased when combined with Methylergometrine. |
Mycophenolate | Mycophenolate The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Ponatinib. |
Paregoric | Paregoric The metabolism of Morphine can be decreased when combined with Ponatinib. |
Penbutolol | Penbutolol The metabolism of Ponatinib can be decreased when combined with Acebutolol. |
Prednisone | Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Ponatinib. |
Ranitidine | Ranitidine The metabolism of Ponatinib can be decreased when combined with Ranitidine. |
Reserpine | Reserpine The metabolism of Ponatinib can be increased when combined with Reserpine. |
Sumatriptan | Sumatriptan Ponatinib may decrease the excretion rate of Sumatriptan which could result in a higher serum level. |
Tacrolimus | Tacrolimus Tacrolimus may increase the immunosuppressive activities of Ponatinib. |
Triamcinolone | Triamcinolone The metabolism of Ponatinib can be increased when combined with Triamcinolone. |
Doxycycline Injection | Doxycycline Injection The metabolism of Ponatinib can be decreased when combined with Doxycycline. |
Fluconazole Injection | Fluconazole Injection The metabolism of Ponatinib can be decreased when combined with Fluconazole. |
Interferon Beta-1b Injection | Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Ponatinib. |
Interferon Gamma-1b Injection | Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ponatinib. |
Meperidine Injection | Meperidine Injection The metabolism of Ponatinib can be increased when combined with Meperidine. |
Methylprednisolone Injection | Methylprednisolone Injection The metabolism of Ponatinib can be increased when combined with Methylprednisolone. |
Metoclopramide Injection | Metoclopramide Injection The metabolism of Ponatinib can be decreased when combined with Metoclopramide. |
Metronidazole Injection | Metronidazole Injection The metabolism of Ponatinib can be decreased when combined with Metronidazole. |
Morphine Injection | Morphine Injection The metabolism of Morphine can be decreased when combined with Ponatinib. |
Zidovudine Injection | Zidovudine Injection The metabolism of Ponatinib can be decreased when combined with Zidovudine. |
Altretamine | Altretamine The metabolism of Ponatinib can be decreased when combined with Amphetamine. |
Cyclosporine | Cyclosporine Ponatinib may increase the immunosuppressive activities of Cyclosporine. |
Ondansetron | Ondansetron The metabolism of Ponatinib can be decreased when combined with Ondansetron. |
Enoxaparin Injection | Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Ponatinib. |
Torsemide | Torsemide The metabolism of Torasemide can be decreased when combined with Ponatinib. |
Olanzapine | Olanzapine The metabolism of Ponatinib can be decreased when combined with Olanzapine. |
Entacapone | Entacapone The metabolism of Ponatinib can be decreased when combined with Entacapone. |
Hydroxychloroquine | Hydroxychloroquine The metabolism of Ponatinib can be decreased when combined with Hydroxychloroquine. |
Orlistat | Orlistat The metabolism of Ponatinib can be increased when combined with Orlistat. |
Oxcarbazepine | Oxcarbazepine The metabolism of Ponatinib can be increased when combined with Oxcarbazepine. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Ponatinib which could result in a higher serum level. |
Telmisartan | Telmisartan Telmisartan may decrease the excretion rate of Ponatinib which could result in a higher serum level. |
Temozolomide | Temozolomide The risk or severity of adverse effects can be increased when Temozolomide is combined with Ponatinib. |
Zaleplon | Zaleplon The metabolism of Ponatinib can be decreased when combined with Zaleplon. |
Anakinra | Anakinra The metabolism of Ponatinib can be increased when combined with Anakinra. |
Linezolid | Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Ponatinib. |
Pentosan Polysulfate | Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Ponatinib. |
Trimipramine | Trimipramine The serum concentration of Ponatinib can be increased when it is combined with Trimipramine. |
Etanercept Injection | Etanercept Injection The metabolism of Ponatinib can be increased when combined with Etanercept. |
Modafinil | Modafinil The metabolism of Ponatinib can be increased when combined with Modafinil. |
Tenofovir | Tenofovir The metabolism of Tenofovir can be decreased when combined with Ponatinib. |
Sirolimus | Sirolimus The serum concentration of Sirolimus can be increased when it is combined with Ponatinib. |
Dutasteride | Dutasteride The metabolism of Ponatinib can be decreased when combined with Dutasteride. |
Epinephrine Injection | Epinephrine Injection The metabolism of Ponatinib can be decreased when combined with Epinephrine. |
Epirubicin | Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Ponatinib. |
Eplerenone | Eplerenone The metabolism of Ponatinib can be decreased when combined with Eplerenone. |
Escitalopram | Escitalopram The serum concentration of Ponatinib can be increased when it is combined with Escitalopram. |
Zonisamide | Zonisamide The metabolism of Ponatinib can be decreased when combined with Zonisamide. |
Adalimumab Injection | Adalimumab Injection The metabolism of Ponatinib can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The metabolism of Ponatinib can be decreased when combined with Aripiprazole. |
Atomoxetine | Atomoxetine The metabolism of Ponatinib can be decreased when combined with Atomoxetine. |
Ezetimibe | Ezetimibe Ponatinib may decrease the excretion rate of Ezetimibe which could result in a higher serum level. |
Glatiramer Injection | Glatiramer Injection The risk or severity of adverse effects can be increased when Glatiramer is combined with Ponatinib. |
Teriparatide Injection | Teriparatide Injection The therapeutic efficacy of Teriparatide can be decreased when used in combination with Ponatinib. |
Atazanavir | Atazanavir The metabolism of Ponatinib can be decreased when combined with Atazanavir. |
Almotriptan | Almotriptan The metabolism of Almotriptan can be decreased when combined with Ponatinib. |
Eletriptan | Eletriptan The metabolism of Ponatinib can be decreased when combined with Eletriptan. |
Mefloquine | Mefloquine The metabolism of Ponatinib can be decreased when combined with Mefloquine. |
Rosuvastatin | Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Ponatinib. |
Vardenafil | Vardenafil The metabolism of Vardenafil can be decreased when combined with Ponatinib. |
Aprepitant | Aprepitant The metabolism of Ponatinib can be decreased when combined with Aprepitant. |
Tegaserod | Tegaserod The metabolism of Ponatinib can be decreased when combined with Tegaserod. |
Tadalafil | Tadalafil The metabolism of Ponatinib can be decreased when combined with Tadalafil. |
Progesterone | Progesterone The metabolism of Ponatinib can be increased when combined with Progesterone. |
Apomorphine Injection | Apomorphine Injection The metabolism of Ponatinib can be decreased when combined with Apomorphine. |
Darbepoetin Alfa Injection | Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ponatinib. |
Infliximab Injection | Infliximab Injection The metabolism of Ponatinib can be increased when combined with Infliximab. |
Protriptyline | Protriptyline The metabolism of Ponatinib can be decreased when combined with Protriptyline. |
Rifaximin | Rifaximin The serum concentration of Rifaximin can be increased when it is combined with Ponatinib. |
Duloxetine | Duloxetine The metabolism of Ponatinib can be decreased when combined with Duloxetine. |
Norethindrone | Norethindrone The metabolism of Ponatinib can be decreased when combined with Norethisterone. |
Trospium | Trospium The metabolism of Ponatinib can be decreased when combined with Trospium. |
Bosentan | Bosentan The metabolism of Ponatinib can be increased when combined with Bosentan. |
Cinacalcet | Cinacalcet The metabolism of Ponatinib can be decreased when combined with Cinacalcet. |
Natalizumab Injection | Natalizumab Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Natalizumab. |
Erlotinib | Erlotinib The metabolism of Ponatinib can be decreased when combined with Erlotinib. |
Eszopiclone | Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Ponatinib. |
Palifermin | Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Ponatinib. |
Solifenacin | Solifenacin The metabolism of Ponatinib can be decreased when combined with Solifenacin. |
Voriconazole | Voriconazole The metabolism of Ponatinib can be decreased when combined with Voriconazole. |
Dextroamphetamine | Dextroamphetamine The metabolism of Ponatinib can be decreased when combined with Amphetamine. |
Peginterferon Alfa-2a Injection | Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ponatinib. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The metabolism of Ponatinib can be decreased when combined with Peginterferon alfa-2b. |
Darifenacin | Darifenacin The metabolism of Darifenacin can be decreased when combined with Ponatinib. |
Fentanyl | Fentanyl The metabolism of Ponatinib can be decreased when combined with Fentanyl. |
Deferasirox | Deferasirox The metabolism of Ponatinib can be increased when combined with Deferasirox. |
Tipranavir | Tipranavir The metabolism of Tipranavir can be decreased when combined with Ponatinib. |
Felbamate | Felbamate The metabolism of Ponatinib can be increased when combined with Felbamate. |
Ranolazine | Ranolazine The serum concentration of Ranolazine can be increased when it is combined with Ponatinib. |
Abatacept Injection | Abatacept Injection The metabolism of Ponatinib can be increased when combined with Abatacept. |
Imatinib | Imatinib The metabolism of Ponatinib can be decreased when combined with Imatinib. |
Sitagliptin | Sitagliptin The metabolism of Sitagliptin can be decreased when combined with Ponatinib. |
Bevacizumab Injection | Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Ponatinib. |
Gefitinib | Gefitinib The metabolism of Ponatinib can be decreased when combined with Gefitinib. |
Paliperidone | Paliperidone The metabolism of Ponatinib can be decreased when combined with Paliperidone. |
Bortezomib | Bortezomib The serum concentration of Ponatinib can be increased when it is combined with Bortezomib. |
Clofarabine Injection | Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Ponatinib. |
Hepatitis B Vaccine | Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Ponatinib. |
Influenza Vaccine, Inactivated or Recombinant | Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Ponatinib. |
Influenza Vaccine, Live Intranasal | Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Ponatinib. |
Live Shingles (Zoster) Vaccine (ZVL) | Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Ponatinib. |
Oxaliplatin Injection | Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Ponatinib. |
Posaconazole | Posaconazole The metabolism of Ponatinib can be decreased when combined with Posaconazole. |
Primaquine | Primaquine The metabolism of Ponatinib can be decreased when combined with Primaquine. |
Rituximab Injection | Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Ponatinib. |
Darunavir | Darunavir The serum concentration of Darunavir can be increased when it is combined with Ponatinib. |
Pemetrexed Injection | Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Ponatinib. |
Lisdexamfetamine | Lisdexamfetamine The metabolism of Ponatinib can be decreased when combined with Lisdexamfetamine. |
Nabilone | Nabilone The metabolism of Ponatinib can be decreased when combined with Nabilone. |
Vorinostat | Vorinostat The risk or severity of adverse effects can be increased when Vorinostat is combined with Ponatinib. |
Sorafenib | Sorafenib The metabolism of Ponatinib can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib The metabolism of Ponatinib can be decreased when combined with Sunitinib. |
Dronabinol | Dronabinol Dronabinol may decrease the excretion rate of Ponatinib which could result in a higher serum level. |
Lapatinib | Lapatinib The metabolism of Ponatinib can be decreased when combined with Lapatinib. |
Dasatinib | Dasatinib The serum concentration of Dasatinib can be increased when it is combined with Ponatinib. |
Mexiletine | Mexiletine The metabolism of Ponatinib can be decreased when combined with Mexiletine. |
Armodafinil | Armodafinil The metabolism of Ponatinib can be increased when combined with Armodafinil. |
Azacitidine Injection | Azacitidine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Ponatinib. |
Ivermectin | Ivermectin The metabolism of Ivermectin can be increased when combined with Ponatinib. |
Temsirolimus | Temsirolimus The serum concentration of Temsirolimus can be increased when it is combined with Ponatinib. |
Nelarabine Injection | Nelarabine Injection The risk or severity of adverse effects can be increased when Nelarabine is combined with Ponatinib. |
Lenalidomide | Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Ponatinib. |
Nilotinib | Nilotinib The metabolism of Ponatinib can be decreased when combined with Nilotinib. |
Toremifene | Toremifene The serum concentration of Ponatinib can be increased when it is combined with Toremifene. |
Bexarotene | Bexarotene The metabolism of Ponatinib can be increased when combined with Bexarotene. |
Budesonide | Budesonide The metabolism of Budesonide can be increased when combined with Ponatinib. |
Chloramphenicol Injection | Chloramphenicol Injection The metabolism of Ponatinib can be decreased when combined with Chloramphenicol. |
Decitabine Injection | Decitabine Injection The risk or severity of adverse effects can be increased when Decitabine is combined with Ponatinib. |
Etravirine | Etravirine The metabolism of Ponatinib can be increased when combined with Etravirine. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Ponatinib. |
Mitoxantrone Injection | Mitoxantrone Injection The metabolism of Ponatinib can be decreased when combined with Mitoxantrone. |
Desvenlafaxine | Desvenlafaxine The metabolism of Ponatinib can be decreased when combined with Desvenlafaxine. |
Cevimeline | Cevimeline The metabolism of Ponatinib can be decreased when combined with Cevimeline. |
Nebivolol | Nebivolol The metabolism of Ponatinib can be decreased when combined with Nebivolol. |
Tretinoin | Tretinoin The metabolism of Ponatinib can be decreased when combined with Tretinoin. |
Bendamustine Injection | Bendamustine Injection The serum concentration of Ponatinib can be increased when it is combined with Bendamustine. |
Pilocarpine | Pilocarpine The metabolism of Ponatinib can be decreased when combined with Pilocarpine. |
Flecainide | Flecainide The metabolism of Flecainide can be decreased when combined with Ponatinib. |
Certolizumab Injection | Certolizumab Injection The metabolism of Ponatinib can be increased when combined with Certolizumab pegol. |
Ixabepilone Injection | Ixabepilone Injection The risk or severity of adverse effects can be increased when Ixabepilone is combined with Ponatinib. |
Irinotecan Injection | Irinotecan Injection The metabolism of Ponatinib can be decreased when combined with Irinotecan. |
Estramustine | Estramustine The risk or severity of adverse effects can be increased when Estramustine is combined with Ponatinib. |
Praziquantel | Praziquantel The metabolism of Ponatinib can be decreased when combined with Praziquantel. |
Mitotane | Mitotane The metabolism of Ponatinib can be increased when combined with Mitotane. |
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) | Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Ponatinib. |
Rufinamide | Rufinamide The metabolism of Ponatinib can be increased when combined with Rufinamide. |
Silodosin | Silodosin The serum concentration of Silodosin can be increased when it is combined with Ponatinib. |
Midazolam | Midazolam The metabolism of Ponatinib can be decreased when combined with Midazolam. |
Dexrazoxane Injection | Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Ponatinib. |
Eltrombopag | Eltrombopag The metabolism of Ponatinib can be decreased when combined with Eltrombopag. |
Ibritumomab Injection | Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Ponatinib. |
Milnacipran | Milnacipran The metabolism of Ponatinib can be decreased when combined with Milnacipran. |
Fesoterodine | Fesoterodine The metabolism of Ponatinib can be decreased when combined with Fesoterodine. |
Betaxolol | Betaxolol The metabolism of Ponatinib can be decreased when combined with Betaxolol. |
Iloperidone | Iloperidone The metabolism of Ponatinib can be decreased when combined with Iloperidone. |
Prasugrel | Prasugrel The risk or severity of bleeding can be increased when Prasugrel is combined with Ponatinib. |
Lacosamide | Lacosamide The metabolism of Ponatinib can be decreased when combined with Lacosamide. |
Everolimus | Everolimus The serum concentration of Everolimus can be increased when it is combined with Ponatinib. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) The serum concentration of Tolvaptan can be increased when it is combined with Ponatinib. |
Dronedarone | Dronedarone The serum concentration of Dronedarone can be increased when it is combined with Ponatinib. |
Pralatrexate Injection | Pralatrexate Injection The risk or severity of adverse effects can be increased when Pralatrexate is combined with Ponatinib. |
Palonosetron Injection | Palonosetron Injection The metabolism of Ponatinib can be decreased when combined with Palonosetron. |
Saxagliptin | Saxagliptin The metabolism of Ponatinib can be decreased when combined with Saxagliptin. |
Romidepsin Injection | Romidepsin Injection The serum concentration of Romidepsin can be increased when it is combined with Ponatinib. |
Tapentadol | Tapentadol The metabolism of Ponatinib can be decreased when combined with Tapentadol. |
Topotecan | Topotecan The serum concentration of Topotecan can be increased when it is combined with Ponatinib. |
Golimumab Injection | Golimumab Injection The metabolism of Ponatinib can be increased when combined with Golimumab. |
Pazopanib | Pazopanib The serum concentration of Pazopanib can be increased when it is combined with Ponatinib. |
Pitavastatin | Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Ponatinib. |
Albendazole | Albendazole The metabolism of Ponatinib can be decreased when combined with Albendazole. |
Levonorgestrel | Levonorgestrel The metabolism of Ponatinib can be decreased when combined with Levonorgestrel. |
Oxymorphone | Oxymorphone The metabolism of Ponatinib can be decreased when combined with Oxymorphone. |
Denosumab Injection | Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Ponatinib. |
Dabigatran | Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Ponatinib. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Ponatinib can be increased when combined with Tocilizumab. |
Fingolimod | Fingolimod Ponatinib may increase the immunosuppressive activities of Fingolimod. |
Eribulin Injection | Eribulin Injection The risk or severity of adverse effects can be increased when Eribulin is combined with Ponatinib. |
Cabazitaxel Injection | Cabazitaxel Injection The serum concentration of Ponatinib can be increased when it is combined with Cabazitaxel. |
Acetaminophen Injection | Acetaminophen Injection The metabolism of Acetaminophen can be increased when combined with Ponatinib. |
Vilazodone | Vilazodone The metabolism of Ponatinib can be decreased when combined with Vilazodone. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection The metabolism of Ponatinib can be decreased when combined with Aldesleukin. |
Sipuleucel-T Injection | Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Ponatinib. |
Belimumab Injection | Belimumab Injection The risk or severity of adverse effects can be increased when Belimumab is combined with Ponatinib. |
Busulfan Injection | Busulfan Injection The risk or severity of adverse effects can be increased when Busulfan is combined with Ponatinib. |
Roflumilast | Roflumilast Roflumilast may increase the immunosuppressive activities of Ponatinib. |
Linagliptin | Linagliptin The metabolism of Ponatinib can be decreased when combined with Linagliptin. |
Rilpivirine | Rilpivirine The metabolism of Rilpivirine can be decreased when combined with Ponatinib. |
Telaprevir | Telaprevir The metabolism of Glecaprevir can be decreased when combined with Ponatinib. |
Potassium Iodide | Potassium Iodide The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Ponatinib. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Ponatinib can be increased when combined with Cyclophosphamide. |
Abiraterone | Abiraterone The metabolism of Ponatinib can be decreased when combined with Abiraterone. |
Rivaroxaban | Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Ponatinib. |
Ticagrelor | Ticagrelor The metabolism of Ponatinib can be decreased when combined with Ticagrelor. |
Brentuximab Vedotin Injection | Brentuximab Vedotin Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Ponatinib. |
Ruxolitinib | Ruxolitinib The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Ponatinib. |
Vandetanib | Vandetanib Vandetanib may decrease the excretion rate of Ponatinib which could result in a higher serum level. |
Clobazam | Clobazam The metabolism of Clobazam can be decreased when combined with Ponatinib. |
Vemurafenib | Vemurafenib The serum concentration of Vemurafenib can be increased when it is combined with Ponatinib. |
Vismodegib | Vismodegib The metabolism of Ponatinib can be decreased when combined with Vismodegib. |
Belatacept Injection | Belatacept Injection The risk or severity of adverse effects can be increased when Belatacept is combined with Ponatinib. |
Ivacaftor | Ivacaftor The metabolism of Ponatinib can be decreased when combined with Ivacaftor. |
Basiliximab Injection | Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Ponatinib. |
Axitinib | Axitinib The serum concentration of Ponatinib can be increased when it is combined with Axitinib. |
Crizotinib | Crizotinib The metabolism of Ponatinib can be decreased when combined with Crizotinib. |
Melphalan Injection | Melphalan Injection The risk or severity of adverse effects can be increased when Melphalan is combined with Ponatinib. |
Cabergoline | Cabergoline The metabolism of Ponatinib can be decreased when combined with Cabergoline. |
Naloxone Injection | Naloxone Injection The metabolism of Ponatinib can be decreased when combined with Naloxone. |
Ambrisentan | Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Ponatinib. |
Eculizumab Injection | Eculizumab Injection The risk or severity of adverse effects can be increased when Eculizumab is combined with Ponatinib. |
Fondaparinux Injection | Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Ponatinib. |
Carfilzomib Injection | Carfilzomib Injection The serum concentration of Ponatinib can be increased when it is combined with Carfilzomib. |
Iloprost | Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Ponatinib. |
Enzalutamide | Enzalutamide The metabolism of Ponatinib can be increased when combined with Enzalutamide. |
Mirabegron | Mirabegron The serum concentration of Ponatinib can be increased when it is combined with Mirabegron. |
Regorafenib | Regorafenib The metabolism of Ponatinib can be decreased when combined with Regorafenib. |
Bosutinib | Bosutinib The serum concentration of Bosutinib can be increased when it is combined with Ponatinib. |
Corticotropin, Repository Injection | Corticotropin, Repository Injection The metabolism of Ponatinib can be increased when combined with Corticotropin. |
Teriflunomide | Teriflunomide The metabolism of Ponatinib can be decreased when combined with Teriflunomide. |
Cabozantinib (thyroid cancer) | Cabozantinib (thyroid cancer) The metabolism of Ponatinib can be decreased when combined with Cabozantinib. |
Icosapent Ethyl | Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Ponatinib. |
Tofacitinib | Tofacitinib Ponatinib may increase the immunosuppressive activities of Tofacitinib. |
Alogliptin | Alogliptin The metabolism of Ponatinib can be decreased when combined with Alogliptin. |
Dimethyl Fumarate | Dimethyl Fumarate The risk or severity of adverse effects can be increased when Ponatinib is combined with Dimethyl fumarate. |
Pomalidomide | Pomalidomide The serum concentration of Pomalidomide can be increased when it is combined with Ponatinib. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The serum concentration of Ponatinib can be increased when it is combined with Trastuzumab emtansine. |
Apixaban | Apixaban The metabolism of Apixaban can be decreased when combined with Ponatinib. |
Canagliflozin | Canagliflozin The serum concentration of Canagliflozin can be increased when it is combined with Ponatinib. |
Dabrafenib | Dabrafenib The serum concentration of Ponatinib can be increased when it is combined with Dabrafenib. |
Ospemifene | Ospemifene The metabolism of Ponatinib can be decreased when combined with Ospemifene. |
Trametinib | Trametinib The metabolism of Ponatinib can be increased when combined with Trametinib. |
Dolutegravir | Dolutegravir The serum concentration of Dolutegravir can be increased when it is combined with Ponatinib. |
Afatinib | Afatinib The serum concentration of Afatinib can be increased when it is combined with Ponatinib. |
Levomilnacipran | Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Ponatinib. |
Vortioxetine | Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Ponatinib. |
Perampanel | Perampanel The metabolism of Ponatinib can be increased when combined with Perampanel. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Ponatinib. |
Lomitapide | Lomitapide The metabolism of Lomitapide can be decreased when combined with Ponatinib. |
Ketorolac Injection | Ketorolac Injection The metabolism of Ketorolac can be decreased when combined with Ponatinib. |
Obinutuzumab Injection | Obinutuzumab Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Obinutuzumab. |
Simeprevir | Simeprevir The metabolism of Ponatinib can be decreased when combined with Simeprevir. |
Sofosbuvir | Sofosbuvir The serum concentration of Sofosbuvir can be increased when it is combined with Ponatinib. |
Dapagliflozin | Dapagliflozin The metabolism of Ponatinib can be decreased when combined with Dapagliflozin. |
Apremilast | Apremilast The metabolism of Ponatinib can be increased when combined with Apremilast. |
Ceritinib | Ceritinib The serum concentration of Ceritinib can be increased when it is combined with Ponatinib. |
Siltuximab Injection | Siltuximab Injection The metabolism of Ponatinib can be increased when combined with Siltuximab. |
Eslicarbazepine | Eslicarbazepine The metabolism of Ponatinib can be increased when combined with Eslicarbazepine. |
Vedolizumab Injection | Vedolizumab Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Vedolizumab. |
Belinostat Injection | Belinostat Injection The risk or severity of adverse effects can be increased when Belinostat is combined with Ponatinib. |
Idelalisib | Idelalisib The risk or severity of adverse effects can be increased when Ponatinib is combined with Idelalisib. |
Testosterone Injection | Testosterone Injection The metabolism of Testosterone can be increased when combined with Ponatinib. |
Oritavancin Injection | Oritavancin Injection The metabolism of Ponatinib can be increased when combined with Oritavancin. |
Vorapaxar | Vorapaxar The metabolism of Ponatinib can be decreased when combined with Vorapaxar. |
Hydrocodone | Hydrocodone The metabolism of Ponatinib can be decreased when combined with Hydrocodone. |
Suvorexant | Suvorexant The metabolism of Ponatinib can be decreased when combined with Suvorexant. |
Edoxaban | Edoxaban The serum concentration of Edoxaban can be increased when it is combined with Ponatinib. |
Peginterferon Beta-1a Injection | Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Peginterferon beta-1a. |
Olaparib | Olaparib The metabolism of Olaparib can be decreased when combined with Ponatinib. |
Blinatumomab Injection | Blinatumomab Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Blinatumomab. |
Methamphetamine | Methamphetamine The metabolism of Ponatinib can be decreased when combined with Metamfetamine. |
Tasimelteon | Tasimelteon The metabolism of Ponatinib can be decreased when combined with Tasimelteon. |
Riociguat | Riociguat The metabolism of Riociguat can be decreased when combined with Ponatinib. |
Lanreotide Injection | Lanreotide Injection The metabolism of Ponatinib can be decreased when combined with Lanreotide. |
Pirfenidone | Pirfenidone The risk or severity of adverse effects can be increased when Pirfenidone is combined with Ponatinib. |
Nintedanib | Nintedanib The metabolism of Nintedanib can be decreased when combined with Ponatinib. |
Secukinumab Injection | Secukinumab Injection The metabolism of Ponatinib can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection The metabolism of Ponatinib can be decreased when combined with Risperidone. |
Palbociclib | Palbociclib The metabolism of Palbociclib can be decreased when combined with Ponatinib. |
Lenvatinib | Lenvatinib The metabolism of Lenvatinib can be increased when combined with Ponatinib. |
Naloxegol | Naloxegol The serum concentration of Naloxegol can be increased when it is combined with Ponatinib. |
Panobinostat | Panobinostat The metabolism of Ponatinib can be decreased when combined with Panobinostat. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Dinutuximab. |
Haloperidol Injection | Haloperidol Injection The serum concentration of Ponatinib can be increased when it is combined with Haloperidol. |
Isavuconazonium Injection | Isavuconazonium Injection The metabolism of Ponatinib can be increased when combined with Isavuconazonium. |
Rolapitant | Rolapitant The metabolism of Ponatinib can be decreased when combined with Rolapitant. |
Prednisolone | Prednisolone The metabolism of Ponatinib can be increased when combined with Prednisolone. |
Daclatasvir | Daclatasvir The metabolism of Ponatinib can be decreased when combined with Daclatasvir. |
Brexpiprazole | Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Ponatinib. |
Ziprasidone Injection | Ziprasidone Injection The metabolism of Ponatinib can be decreased when combined with Ziprasidone. |
Cariprazine | Cariprazine The metabolism of Ponatinib can be decreased when combined with Cariprazine. |
Cobimetinib | Cobimetinib The serum concentration of Cobimetinib can be increased when it is combined with Ponatinib. |
Mepolizumab Injection | Mepolizumab Injection The risk or severity of adverse effects can be increased when Mepolizumab is combined with Ponatinib. |
Trabectedin Injection | Trabectedin Injection The metabolism of Ponatinib can be decreased when combined with Trabectedin. |
Osimertinib | Osimertinib The metabolism of Osimertinib can be increased when combined with Ponatinib. |
Alectinib | Alectinib Alectinib may decrease the excretion rate of Ponatinib which could result in a higher serum level. |
Rifapentine | Rifapentine The metabolism of Ponatinib can be increased when combined with Rifapentine. |
Lesinurad | Lesinurad The metabolism of Ponatinib can be increased when combined with Lesinurad. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection The metabolism of Ponatinib can be decreased when combined with Amphotericin B. |
Dexamethasone Injection | Dexamethasone Injection The metabolism of Ponatinib can be increased when combined with Dexamethasone. |
Defibrotide Injection | Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Ponatinib. |
Ixekizumab Injection | Ixekizumab Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Ixekizumab. |
Venetoclax | Venetoclax The serum concentration of Venetoclax can be increased when it is combined with Ponatinib. |
Cobicistat | Cobicistat The metabolism of Ponatinib can be decreased when combined with Cobicistat. |
Selexipag | Selexipag The metabolism of Selexipag can be decreased when combined with Ponatinib. |
Diphenhydramine Injection | Diphenhydramine Injection The metabolism of Ponatinib can be decreased when combined with Diphenhydramine. |
Rucaparib | Rucaparib The metabolism of Rucaparib can be decreased when combined with Ponatinib. |
Ribociclib | Ribociclib The metabolism of Ponatinib can be decreased when combined with Ribociclib. |
Brodalumab Injection | Brodalumab Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Brodalumab. |
Parathyroid Hormone Injection | Parathyroid Hormone Injection The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Ponatinib. |
Brigatinib | Brigatinib The metabolism of Brigatinib can be increased when combined with Ponatinib. |
Doxepin (Insomnia) | Doxepin (Insomnia) The metabolism of Ponatinib can be decreased when combined with Doxepin. |
Deutetrabenazine | Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Ponatinib. |
Valbenazine | Valbenazine The metabolism of Valbenazine can be decreased when combined with Ponatinib. |
Deflazacort | Deflazacort The metabolism of Deflazacort can be increased when combined with Ponatinib. |
Safinamide | Safinamide The metabolism of Ponatinib can be decreased when combined with Safinamide. |
Ocrelizumab Injection | Ocrelizumab Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Ocrelizumab. |
Sarilumab Injection | Sarilumab Injection The metabolism of Sarilumab can be increased when combined with Ponatinib. |
Midostaurin | Midostaurin The metabolism of Ponatinib can be decreased when combined with Midostaurin. |
Guselkumab Injection | Guselkumab Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Guselkumab. |
Abaloparatide Injection | Abaloparatide Injection The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Ponatinib. |
Enasidenib | Enasidenib The metabolism of Ponatinib can be decreased when combined with Enasidenib. |
Inotuzumab Ozogamicin Injection | Inotuzumab Ozogamicin Injection The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Ponatinib. |
Aprepitant/Fosaprepitant Injection | Aprepitant/Fosaprepitant Injection The metabolism of Ponatinib can be increased when combined with Fosaprepitant. |
Copanlisib Injection | Copanlisib Injection The serum concentration of Copanlisib can be increased when it is combined with Ponatinib. |
Delafloxacin | Delafloxacin Ponatinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level. |
Abemaciclib | Abemaciclib The serum concentration of Abemaciclib can be increased when it is combined with Ponatinib. |
Betrixaban | Betrixaban The serum concentration of Betrixaban can be increased when it is combined with Ponatinib. |
Acalabrutinib | Acalabrutinib The metabolism of Ponatinib can be decreased when combined with Acalabrutinib. |
Gemtuzumab Ozogamicin Injection | Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ponatinib. |
Letermovir | Letermovir The metabolism of Ponatinib can be decreased when combined with Letermovir. |
Tetrabenazine | Tetrabenazine The metabolism of Ponatinib can be decreased when combined with Tetrabenazine. |
Ertugliflozin | Ertugliflozin The serum concentration of Ertugliflozin can be increased when it is combined with Ponatinib. |
Buprenorphine Injection | Buprenorphine Injection The metabolism of Ponatinib can be decreased when combined with Buprenorphine. |
Apalutamide | Apalutamide The metabolism of Ponatinib can be increased when combined with Apalutamide. |
Penicillamine | Penicillamine The risk or severity of adverse effects can be increased when Penicillamine is combined with Ponatinib. |
Fostamatinib | Fostamatinib The metabolism of Ponatinib can be decreased when combined with Fostamatinib. |
Avatrombopag | Avatrombopag The metabolism of Avatrombopag can be increased when combined with Ponatinib. |
Baricitinib | Baricitinib The risk or severity of adverse effects can be increased when Ponatinib is combined with Baricitinib. |
Lofexidine | Lofexidine The metabolism of Ponatinib can be decreased when combined with Lofexidine. |
Eliglustat | Eliglustat The metabolism of Ponatinib can be decreased when combined with Eliglustat. |
Encorafenib | Encorafenib The metabolism of Encorafenib can be decreased when combined with Ponatinib. |
Binimetinib | Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Ponatinib. |
Ivosidenib | Ivosidenib The metabolism of Ivosidenib can be increased when combined with Ponatinib. |
Lusutrombopag | Lusutrombopag The serum concentration of Lusutrombopag can be increased when it is combined with Ponatinib. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Ponatinib. |
Doravirine | Doravirine The metabolism of Doravirine can be decreased when combined with Ponatinib. |
Tafenoquine | Tafenoquine The metabolism of Ponatinib can be decreased when combined with Tafenoquine. |
Cannabidiol | Cannabidiol The metabolism of Ponatinib can be decreased when combined with Cannabidiol. |
Dacomitinib | Dacomitinib The serum concentration of Ponatinib can be increased when it is combined with Dacomitinib. |
Duvelisib | Duvelisib The metabolism of Duvelisib can be decreased when combined with Ponatinib. |
Omadacycline | Omadacycline The serum concentration of Omadacycline can be increased when it is combined with Ponatinib. |
Stiripentol | Stiripentol The metabolism of Ponatinib can be decreased when combined with Stiripentol. |
Talazoparib | Talazoparib The serum concentration of Talazoparib can be increased when it is combined with Ponatinib. |
Gilteritinib | Gilteritinib The metabolism of Ponatinib can be decreased when combined with Gilteritinib. |
Glasdegib | Glasdegib The metabolism of Glasdegib can be decreased when combined with Ponatinib. |
Lorlatinib | Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Ponatinib. |
Larotrectinib | Larotrectinib The serum concentration of Larotrectinib can be increased when it is combined with Ponatinib. |
Methoxy Polyethylene Glycol-Epoetin Beta Injection | Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Ponatinib. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Ponatinib. |
Rifamycin | Rifamycin The metabolism of Rifamycin can be increased when combined with Ponatinib. |
Prucalopride | Prucalopride The serum concentration of Prucalopride can be increased when it is combined with Ponatinib. |
Ravulizumab-cwvz Injection | Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Ravulizumab. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Ponatinib can be increased when combined with Emapalumab. |
Siponimod | Siponimod The risk or severity of adverse effects can be increased when Ponatinib is combined with Siponimod. |
Caplacizumab-yhdp Injection | Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Ponatinib. |
Risankizumab-rzaa Injection | Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Ponatinib is combined with Risankizumab. |
Alpelisib | Alpelisib The serum concentration of Alpelisib can be increased when it is combined with Ponatinib. |
Cladribine | Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Ponatinib. |
Darolutamide | Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Ponatinib. |
Triclabendazole | Triclabendazole The metabolism of Ponatinib can be decreased when combined with Triclabendazole. |
Pexidartinib | Pexidartinib Ponatinib may increase the hepatotoxic activities of Pexidartinib. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Ponatinib. |
Pitolisant | Pitolisant The serum concentration of Ponatinib can be decreased when it is combined with Pitolisant. |
Fedratinib | Fedratinib The metabolism of Ponatinib can be decreased when combined with Fedratinib. |
Lefamulin | Lefamulin Ponatinib may decrease the excretion rate of Lefamulin which could result in a higher serum level. |
Phenytoin Injection | Phenytoin Injection The metabolism of Ponatinib can be decreased when combined with Phenytoin. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Ponatinib. |
Enfortumab vedotin-ejfv Injection | Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Ponatinib. |
Voxelotor | Voxelotor The serum concentration of Ponatinib can be increased when it is combined with Voxelotor. |
Lasmiditan | Lasmiditan The serum concentration of Lasmiditan can be increased when it is combined with Ponatinib. |
Ubrogepant | Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Ponatinib. |
Tazemetostat | Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Ponatinib. |
Cenobamate | Cenobamate The serum concentration of Ponatinib can be decreased when it is combined with Cenobamate. |
Ozanimod | Ozanimod Ponatinib may decrease the excretion rate of Ozanimod which could result in a higher serum level. |
Selumetinib | Selumetinib The metabolism of Selumetinib can be decreased when combined with Ponatinib. |
Rimegepant | Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Ponatinib. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Ponatinib. |
Remdesivir Injection | Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Ponatinib. |
Ripretinib | Ripretinib Ponatinib may decrease the excretion rate of Ripretinib which could result in a higher serum level. |
Selpercatinib | Selpercatinib The serum concentration of Ponatinib can be increased when it is combined with Selpercatinib. |
Capmatinib | Capmatinib The serum concentration of Ponatinib can be increased when it is combined with Capmatinib. |
Lemborexant | Lemborexant The metabolism of Lemborexant can be decreased when combined with Ponatinib. |
Fenfluramine | Fenfluramine The metabolism of Ponatinib can be decreased when combined with Fenfluramine. |
Fostemsavir | Fostemsavir Ponatinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level. |
Octreotide | Octreotide The serum concentration of Ponatinib can be increased when it is combined with Octreotide. |
Belantamab Mafodotin-blmf Injection | Belantamab Mafodotin-blmf Injection The serum concentration of Belantamab mafodotin can be increased when it is combined with Ponatinib. |
Pralsetinib | Pralsetinib The serum concentration of Pralsetinib can be increased when it is combined with Ponatinib. |
Opicapone | Opicapone The metabolism of Ponatinib can be decreased when combined with Opicapone. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Ponatinib can be decreased when it is combined with Satralizumab. |
Relugolix | Relugolix The serum concentration of Relugolix can be increased when it is combined with Ponatinib. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Ponatinib can be decreased when combined with Drospirenone. |
Vitamin E (Alpha-Tocopherol) | Vitamin E (Alpha-Tocopherol) The metabolism of Ponatinib can be increased when combined with Vitamin E. |
Theophylline | Theophylline The metabolism of Theophylline can be decreased when combined with Ponatinib. |
Indomethacin | Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Ponatinib. |
Mefenamic Acid | Mefenamic Acid The metabolism of Ponatinib can be decreased when combined with Mefenamic acid. |
Naproxen | Naproxen The metabolism of Naproxen can be decreased when combined with Ponatinib. |
Trazodone | Trazodone The metabolism of Ponatinib can be decreased when combined with Trazodone. |
Hydroxyurea | Hydroxyurea The metabolism of Ponatinib can be decreased when combined with Hydroxyurea. |
Floxuridine | Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Ponatinib. |
Phenobarbital | Phenobarbital The metabolism of Ponatinib can be increased when combined with Phenobarbital. |
Methotrexate Injection | Methotrexate Injection The risk or severity of adverse effects can be increased when Methotrexate is combined with Ponatinib. |
Primidone | Primidone The metabolism of Ponatinib can be increased when combined with Primidone. |
Chlorpromazine | Chlorpromazine The metabolism of Ponatinib can be decreased when combined with Chlorpromazine. |
Diazepam | Diazepam The metabolism of Ponatinib can be decreased when combined with Diazepam. |
Lorazepam | Lorazepam The metabolism of Ponatinib can be decreased when combined with Lorazepam. |
Carmustine | Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Ponatinib. |
Codeine | Codeine The metabolism of Ponatinib can be decreased when combined with Codeine. |
Bromocriptine | Bromocriptine The metabolism of Ponatinib can be decreased when combined with Bromocriptine. |
Tranylcypromine | Tranylcypromine The metabolism of Ponatinib can be decreased when combined with Tranylcypromine. |
Phenelzine | Phenelzine The metabolism of Ponatinib can be decreased when combined with Phenelzine. |
Procarbazine | Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Ponatinib. |
Tetracycline | Tetracycline The metabolism of Ponatinib can be decreased when combined with Tetracycline. |
Thioguanine | Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Ponatinib. |
Prochlorperazine | Prochlorperazine The metabolism of Ponatinib can be decreased when combined with Prochlorperazine. |
Thioridazine | Thioridazine The metabolism of Ponatinib can be decreased when combined with Thioridazine. |
Bleomycin | Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Ponatinib. |
Dapsone | Dapsone The metabolism of Dapsone can be decreased when combined with Ponatinib. |
Sulfadiazine | Sulfadiazine The metabolism of Sulfadiazine can be decreased when combined with Ponatinib. |
Oxycodone | Oxycodone The metabolism of Ponatinib can be decreased when combined with Oxycodone. |
Methadone | Methadone The metabolism of Methadone can be increased when combined with Ponatinib. |
Oxybutynin | Oxybutynin The metabolism of Ponatinib can be decreased when combined with Oxybutynin. |
Benztropine | Benztropine The metabolism of Ponatinib can be decreased when combined with Benzatropine. |
Maprotiline | Maprotiline The metabolism of Ponatinib can be decreased when combined with Maprotiline. |
Ibuprofen | Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Ponatinib. |
Orphenadrine | Orphenadrine The metabolism of Ponatinib can be decreased when combined with Orphenadrine. |
Perphenazine | Perphenazine The metabolism of Perphenazine can be decreased when combined with Ponatinib. |
Azathioprine | Azathioprine The risk or severity of adverse effects can be increased when Azathioprine is combined with Ponatinib. |
Fluphenazine | Fluphenazine The metabolism of Ponatinib can be decreased when combined with Fluphenazine. |
Phentermine | Phentermine The metabolism of Ponatinib can be decreased when combined with Phentermine. |
Amoxapine | Amoxapine The metabolism of Ponatinib can be decreased when combined with Amoxapine. |
Sulfasalazine | Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ponatinib. |
Hydrocortisone | Hydrocortisone The metabolism of Ponatinib can be increased when combined with Hydrocortisone. |
Lomustine | Lomustine The risk or severity of adverse effects can be increased when Lomustine is combined with Ponatinib. |
Doxorubicin | Doxorubicin The serum concentration of Doxorubicin can be increased when it is combined with Ponatinib. |
Cytarabine | Cytarabine The risk or severity of adverse effects can be increased when Cytarabine is combined with Ponatinib. |
Mechlorethamine | Mechlorethamine The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Ponatinib. |
Dactinomycin | Dactinomycin The serum concentration of Ponatinib can be increased when it is combined with Dactinomycin. |
Carbamazepine | Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Ponatinib. |
Clonidine | Clonidine The metabolism of Ponatinib can be decreased when combined with Clonidine. |
Prazosin | Prazosin Ponatinib may decrease the excretion rate of Prazosin which could result in a higher serum level. |
Hydralazine | Hydralazine The metabolism of Ponatinib can be decreased when combined with Hydralazine. |
Cimetidine | Cimetidine The metabolism of Ponatinib can be decreased when combined with Cimetidine. |
Warfarin | Warfarin The metabolism of Ponatinib can be increased when combined with Warfarin. |
Loperamide | Loperamide The metabolism of Ponatinib can be decreased when combined with Loperamide. |
Promethazine | Promethazine The metabolism of Ponatinib can be decreased when combined with Promethazine. |
Daunorubicin | Daunorubicin The metabolism of Ponatinib can be decreased when combined with Daunorubicin. |
Nitrofurantoin | Nitrofurantoin Ponatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Griseofulvin | Griseofulvin The metabolism of Ponatinib can be increased when combined with Griseofulvin. |
Digoxin | Digoxin Ponatinib may decrease the excretion rate of Digoxin which could result in a higher serum level. |
Chloroquine | Chloroquine The metabolism of Ponatinib can be decreased when combined with Chloroquine. |
Quinine | Quinine The metabolism of Ponatinib can be decreased when combined with Quinine. |
Calcitriol | Calcitriol The metabolism of Ponatinib can be increased when combined with Calcitriol. |
Sulfinpyrazone | Sulfinpyrazone The metabolism of Ponatinib can be increased when combined with Sulfinpyrazone. |
Chlorothiazide | Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Ponatinib. |
Clindamycin Injection | Clindamycin Injection The metabolism of Ponatinib can be decreased when combined with Clindamycin. |
Secobarbital | Secobarbital The metabolism of Ponatinib can be increased when combined with Secobarbital. |
Desipramine | Desipramine The metabolism of Desipramine can be decreased when combined with Ponatinib. |
Amitriptyline | Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Ponatinib. |
Imipramine | Imipramine The metabolism of Imipramine can be decreased when combined with Ponatinib. |
Probenecid | Probenecid The metabolism of Ponatinib can be increased when combined with Probenecid. |
Quinidine | Quinidine The serum concentration of Quinidine can be increased when it is combined with Ponatinib. |
Procainamide | Procainamide The metabolism of Procainamide can be decreased when combined with Ponatinib. |
Isoniazid | Isoniazid The metabolism of Ponatinib can be decreased when combined with Isoniazid. |
Rifampin | Rifampin The metabolism of Ponatinib can be increased when combined with Rifampicin. |
Valproic Acid | Valproic Acid The metabolism of Ponatinib can be decreased when combined with Valproic acid. |
Tamoxifen | Tamoxifen The metabolism of Tamoxifen can be increased when combined with Ponatinib. |
Mitomycin | Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Ponatinib. |
Levothyroxine | Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Ponatinib. |
Liothyronine | Liothyronine The therapeutic efficacy of Liothyronine can be decreased when used in combination with Ponatinib. |
Methimazole | Methimazole The metabolism of Ponatinib can be decreased when combined with Methimazole. |
Propylthiouracil | Propylthiouracil The therapeutic efficacy of Ponatinib can be decreased when used in combination with Propylthiouracil. |
Tolbutamide | Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Ponatinib. |
Dextromethorphan | Dextromethorphan The metabolism of Ponatinib can be decreased when combined with Dextromethorphan. |
Niacin | Niacin The metabolism of Ponatinib can be decreased when combined with Niacin. |
Clemastine | Clemastine The metabolism of Ponatinib can be decreased when combined with Clemastine. |
Chlorpheniramine | Chlorpheniramine The metabolism of Ponatinib can be decreased when combined with Chlorpheniramine. |
Meclizine | Meclizine The metabolism of Ponatinib can be decreased when combined with Meclizine. |
Methyclothiazide | Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Ponatinib. |
Hydrochlorothiazide | Hydrochlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Ponatinib. |
Chlorzoxazone | Chlorzoxazone The metabolism of Ponatinib can be decreased when combined with Chlorzoxazone. |
Folic Acid | Folic Acid Ponatinib may decrease the excretion rate of Folic acid which could result in a higher serum level. |
Danazol | Danazol The metabolism of Ponatinib can be decreased when combined with Danazol. |
Disulfiram | Disulfiram The metabolism of Ponatinib can be decreased when combined with Disulfiram. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The metabolism of Ponatinib can be decreased when combined with Propranolol. |
Nortriptyline | Nortriptyline The serum concentration of Nortriptyline can be increased when it is combined with Ponatinib. |
Spironolactone | Spironolactone The metabolism of Ponatinib can be decreased when combined with Spironolactone. |
Amphotericin B Injection | Amphotericin B Injection The metabolism of Ponatinib can be decreased when combined with Amphotericin B. |
Mercaptopurine | Mercaptopurine The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Ponatinib. |
Nadolol | Nadolol The metabolism of Ponatinib can be decreased when combined with Nadolol. |
Allopurinol | Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Ponatinib. |
Clomiphene | Clomiphene The serum concentration of Clomifene can be increased when it is combined with Ponatinib. |
Fluorouracil Injection | Fluorouracil Injection The metabolism of Ponatinib can be decreased when combined with Fluorouracil. |
Colchicine | Colchicine The serum concentration of Colchicine can be increased when it is combined with Ponatinib. |
Cephalexin | Cephalexin The metabolism of Ponatinib can be decreased when combined with Cephalexin. |
Dacarbazine | Dacarbazine The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ponatinib. |
Acetazolamide | Acetazolamide The metabolism of Ponatinib can be decreased when combined with Acetazolamide. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ponatinib. |
Bacillus Calmette-Guerin (BCG) Vaccine | Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Ponatinib. |
Ketoconazole | Ketoconazole The metabolism of Ponatinib can be decreased when combined with Ketoconazole. |
Thiotepa Injection | Thiotepa Injection The risk or severity of adverse effects can be increased when Thiotepa is combined with Ponatinib. |
Vincristine Injection | Vincristine Injection The excretion of Vincristine can be decreased when combined with Ponatinib. |
Dipyridamole | Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Ponatinib. |
Vinblastine | Vinblastine The serum concentration of Ponatinib can be increased when it is combined with Vinblastine. |
Metoprolol | Metoprolol The metabolism of Metoprolol can be decreased when combined with Ponatinib. |
Hydroxyzine | Hydroxyzine The metabolism of Ponatinib can be decreased when combined with Hydroxyzine. |
Aspirin | Aspirin The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Ponatinib. |
Chlorambucil | Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Ponatinib. |
Alprazolam | Alprazolam The metabolism of Ponatinib can be decreased when combined with Alprazolam. |
Triazolam | Triazolam The metabolism of Ponatinib can be decreased when combined with Triazolam. |
Trimethoprim | Trimethoprim The metabolism of Ponatinib can be decreased when combined with Trimethoprim. |
Diltiazem | Diltiazem The metabolism of Ponatinib can be decreased when combined with Diltiazem. |
Nifedipine | Nifedipine The metabolism of Ponatinib can be increased when combined with Nifedipine. |
Timolol | Timolol The metabolism of Ponatinib can be decreased when combined with Timolol. |
Verapamil | Verapamil The metabolism of Ponatinib can be decreased when combined with Verapamil. |
Atenolol | Atenolol The metabolism of Ponatinib can be decreased when combined with Atenolol. |
Pindolol | Pindolol The metabolism of Ponatinib can be decreased when combined with Pindolol. |
Cisplatin Injection | Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Ponatinib. |
Piroxicam | Piroxicam The metabolism of Ponatinib can be decreased when combined with Piroxicam. |
Streptozocin | Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Ponatinib. |
Etoposide | Etoposide The serum concentration of Ponatinib can be increased when it is combined with Etoposide. |
Glyburide | Glyburide The metabolism of Glyburide can be decreased when combined with Ponatinib. |
Dicloxacillin | Dicloxacillin The metabolism of Ponatinib can be increased when combined with Dicloxacillin. |
Nafcillin Injection | Nafcillin Injection The metabolism of Ponatinib can be increased when combined with Nafcillin. |
Pentoxifylline | Pentoxifylline The risk or severity of bleeding can be increased when Pentoxifylline is combined with Ponatinib. |
Pentamidine Injection | Pentamidine Injection The metabolism of Ponatinib can be decreased when combined with Pentamidine. |
Labetalol | Labetalol The metabolism of Ponatinib can be decreased when combined with Labetalol. |
Gemfibrozil | Gemfibrozil The metabolism of Ponatinib can be decreased when combined with Gemfibrozil. |
Ketoprofen | Ketoprofen The metabolism of Ponatinib can be decreased when combined with Ketoprofen. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Ponatinib. |
Amiodarone | Amiodarone The metabolism of Amiodarone can be decreased when combined with Ponatinib. |
Buspirone | Buspirone The metabolism of Ponatinib can be decreased when combined with Buspirone. |
Lovastatin | Lovastatin The metabolism of Lovastatin can be decreased when combined with Ponatinib. |
Ciprofloxacin | Ciprofloxacin The metabolism of Ponatinib can be decreased when combined with Ciprofloxacin. |
Diclofenac | Diclofenac The metabolism of Diclofenac can be decreased when combined with Ponatinib. |
Fluoxetine | Fluoxetine The serum concentration of Ponatinib can be increased when it is combined with Fluoxetine. |
Interferon Alfa-2b Injection | Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Ponatinib. |
Clozapine | Clozapine The risk or severity of neutropenia can be increased when Ponatinib is combined with Clozapine. |
Idarubicin | Idarubicin The metabolism of Ponatinib can be decreased when combined with Idarubicin. |
Fludarabine Injection | Fludarabine Injection The risk or severity of adverse effects can be increased when Fludarabine is combined with Ponatinib. |
Pentostatin Injection | Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Ponatinib. |
Clarithromycin | Clarithromycin The metabolism of Ponatinib can be decreased when combined with Clarithromycin. |
Felodipine | Felodipine The metabolism of Felodipine can be decreased when combined with Ponatinib. |
Pravastatin | Pravastatin The serum concentration of Pravastatin can be increased when it is combined with Ponatinib. |
Simvastatin | Simvastatin The metabolism of Simvastatin can be decreased when combined with Ponatinib. |
Epoetin Alfa, Injection | Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ponatinib. |
Teniposide Injection | Teniposide Injection The metabolism of Ponatinib can be decreased when combined with Teniposide. |
Itraconazole | Itraconazole The metabolism of Ponatinib can be decreased when combined with Itraconazole. |
Rifabutin | Rifabutin The metabolism of Ponatinib can be increased when combined with Rifabutin. |
Sotalol | Sotalol The metabolism of Sotalol can be decreased when combined with Ponatinib. |
Bisoprolol | Bisoprolol The serum concentration of Bisoprolol can be increased when it is combined with Ponatinib. |
Zolpidem | Zolpidem The metabolism of Ponatinib can be decreased when combined with Zolpidem. |
Doxazosin | Doxazosin The metabolism of Ponatinib can be decreased when combined with Doxazosin. |
Isradipine | Isradipine The metabolism of Ponatinib can be decreased when combined with Isradipine. |
Omeprazole | Omeprazole The metabolism of Ponatinib can be increased when combined with Omeprazole. |
Cisapride | Cisapride The metabolism of Ponatinib can be decreased when combined with Cisapride. |
Fluvastatin | Fluvastatin The metabolism of Ponatinib can be decreased when combined with Fluvastatin. |
Venlafaxine | Venlafaxine The metabolism of Ponatinib can be decreased when combined with Venlafaxine. |
Famciclovir | Famciclovir The metabolism of Ponatinib can be decreased when combined with Famciclovir. |
Fluvoxamine | Fluvoxamine The metabolism of Ponatinib can be decreased when combined with Fluvoxamine. |
Nefazodone | Nefazodone The metabolism of Ponatinib can be decreased when combined with Nefazodone. |
Losartan | Losartan The metabolism of Ponatinib can be decreased when combined with Losartan. |
Tramadol | Tramadol The metabolism of Ponatinib can be decreased when combined with Tramadol. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Ponatinib can be decreased when combined with Vinorelbine. |
Carboplatin Injection | Carboplatin Injection The risk or severity of adverse effects can be increased when Carboplatin is combined with Ponatinib. |
Lansoprazole | Lansoprazole The metabolism of Ponatinib can be increased when combined with Lansoprazole. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Ponatinib can be increased when combined with Ifosfamide. |
Pegaspargase Injection | Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Ponatinib. |
Nicardipine | Nicardipine The metabolism of Ponatinib can be decreased when combined with Nicardipine. |
Bupropion | Bupropion The metabolism of Ponatinib can be decreased when combined with Bupropion. |
Ticlopidine | Ticlopidine The metabolism of Ponatinib can be decreased when combined with Ticlopidine. |
Saquinavir | Saquinavir The metabolism of Saquinavir can be decreased when combined with Ponatinib. |
Dalteparin Injection | Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Ponatinib. |
Nisoldipine | Nisoldipine The metabolism of Ponatinib can be decreased when combined with Nisoldipine. |
Lamivudine | Lamivudine Ponatinib may decrease the excretion rate of Lamivudine which could result in a higher serum level. |
Riluzole | Riluzole Ponatinib may decrease the excretion rate of Riluzole which could result in a higher serum level. |
Anastrozole | Anastrozole The metabolism of Anastrozole can be decreased when combined with Ponatinib. |
Gemcitabine Injection | Gemcitabine Injection The serum concentration of Ponatinib can be increased when it is combined with Gemcitabine. |
Indinavir | Indinavir The metabolism of Ponatinib can be decreased when combined with Indinavir. |
Ritonavir | Ritonavir The metabolism of Ponatinib can be decreased when combined with Ritonavir. |
Docetaxel Injection | Docetaxel Injection The metabolism of Ponatinib can be decreased when combined with Docetaxel. |
Clomipramine | Clomipramine The metabolism of Ponatinib can be decreased when combined with Clomipramine. |
Zafirlukast | Zafirlukast The metabolism of Ponatinib can be decreased when combined with Zafirlukast. |
Mirtazapine | Mirtazapine The metabolism of Ponatinib can be decreased when combined with Mirtazapine. |
Topiramate | Topiramate The metabolism of Ponatinib can be increased when combined with Topiramate. |
Donepezil | Donepezil The metabolism of Donepezil can be decreased when combined with Ponatinib. |
Nelfinavir | Nelfinavir The metabolism of Ponatinib can be decreased when combined with Nelfinavir. |
Fexofenadine | Fexofenadine The serum concentration of Ponatinib can be increased when it is combined with Fexofenadine. |
Azithromycin | Azithromycin The metabolism of Ponatinib can be decreased when combined with Azithromycin. |
Loratadine | Loratadine The metabolism of Ponatinib can be decreased when combined with Loratadine. |
Carvedilol | Carvedilol The metabolism of Ponatinib can be decreased when combined with Carvedilol. |
Nilutamide | Nilutamide The metabolism of Ponatinib can be decreased when combined with Nilutamide. |
Flutamide | Flutamide The metabolism of Ponatinib can be decreased when combined with Flutamide. |
Selegiline | Selegiline The metabolism of Selegiline can be decreased when combined with Ponatinib. |
Bicalutamide | Bicalutamide The metabolism of Ponatinib can be decreased when combined with Bicalutamide. |
Sertraline | Sertraline The metabolism of Ponatinib can be decreased when combined with Sertraline. |
Propafenone | Propafenone The metabolism of Ponatinib can be decreased when combined with Propafenone. |
Raloxifene | Raloxifene The metabolism of Raloxifene can be decreased when combined with Ponatinib. |
Irbesartan | Irbesartan The metabolism of Ponatinib can be decreased when combined with Irbesartan. |
Tamsulosin | Tamsulosin The metabolism of Ponatinib can be decreased when combined with Tamsulosin. |
Finasteride | Finasteride The metabolism of Ponatinib can be decreased when combined with Finasteride. |
Quetiapine | Quetiapine The metabolism of Ponatinib can be decreased when combined with Quetiapine. |
Paroxetine | Paroxetine The metabolism of Ponatinib can be decreased when combined with Paroxetine. |
Citalopram | Citalopram The metabolism of Ponatinib can be decreased when combined with Citalopram. |
Capecitabine | Capecitabine The risk or severity of adverse effects can be increased when Capecitabine is combined with Ponatinib. |
Efavirenz | Efavirenz The metabolism of Ponatinib can be decreased when combined with Efavirenz. |
Sildenafil | Sildenafil The metabolism of Sildenafil can be decreased when combined with Ponatinib. |
Pioglitazone | Pioglitazone The metabolism of Ponatinib can be decreased when combined with Pioglitazone. |
Trastuzumab Injection | Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Ponatinib. |
Celecoxib | Celecoxib The metabolism of Celecoxib can be decreased when combined with Ponatinib. |
Rosiglitazone | Rosiglitazone The metabolism of Ponatinib can be decreased when combined with Rosiglitazone. |
Tolterodine | Tolterodine The metabolism of Ponatinib can be decreased when combined with Tolterodine. |
Thalidomide | Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Ponatinib. |
Nateglinide | Nateglinide The metabolism of Ponatinib can be decreased when combined with Nateglinide. |
Galantamine | Galantamine The metabolism of Ponatinib can be decreased when combined with Galantamine. |
Rabeprazole | Rabeprazole The metabolism of Ponatinib can be decreased when combined with Rabeprazole. |
Terbinafine | Terbinafine The metabolism of Ponatinib can be decreased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists